# Abhishek Mahajan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/abhishek-mahajan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,882 |
| Field | Radiomics and Machine Learning in Medical Imaging |
| h-index | 36 |
| i10-index | 124 |
| Last Known Institution | University of Liverpool |
| OpenAlex ID | https://openalex.org/A5089100168 |
| ORCID iD | 0000-0001-6606-6537 |
| Works | 467 |

## Researcher papers

- [Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer](https://scholariq.org/papers/gefitinib-versus-gefitinib-plus-pemetrexed-and-carboplatin-chemotherapy-in-i/)
- [Federated learning enables big data for rare cancer boundary detection](https://scholariq.org/papers/federated-learning-enables-big-data-for-rare-cancer-boundary-detection/)
- [Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome](https://scholariq.org/papers/imaging-body-composition-in-cancer-patients-visceral-obesity-sarcopenia-and/)
- [Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study](https://scholariq.org/papers/low-dose-immunotherapy-in-head-and-neck-cancer-a-randomized-study/)
- [Lipid profile of coronary risk subjects following yogic lifestyle intervention.](https://scholariq.org/papers/lipid-profile-of-coronary-risk-subjects-following-yogic-lifestyle-intervention/)
- [A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer](https://scholariq.org/papers/a-randomized-phase-3-trial-comparing-nimotuzumab-plus-cisplatin/)
- [Overall Survival Prediction in Glioblastoma With Radiomic Features Using Machine Learning](https://scholariq.org/papers/overall-survival-prediction-in-glioblastoma-with-radiomic-features-using-machine/)
- [A Novel Approach for Fully Automatic Intra-Tumor Segmentation With 3D U-Net Architecture for Gliomas](https://scholariq.org/papers/a-novel-approach-for-fully-automatic-intra-tumor-segmentation-with-3d-u-net/)
- [Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial](https://scholariq.org/papers/low-cost-oral-metronomic-chemotherapy-versus-intravenous-cisplatin-in-patients/)
- [Artificial intelligence in healthcare in developing nations: The beginning of a transformative journey](https://scholariq.org/papers/artificial-intelligence-in-healthcare-in-developing-nations-the-beginning-of-a/)
- [Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patients](https://scholariq.org/papers/repeat-biopsy-in-epidermal-growth-factor-receptor-mutation-positive-nonsmall/)

## Researcher topics

- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Researcher university

- [University of Liverpool](https://scholariq.org/institutions/university-of-liverpool/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.